Diabetes — all decisions

The Board granted service connection for diabetes mellitus type II, ischemic heart disease, and hypertension from August 10, 2022, under the PACT Act. The claim for a thyroid disability was denied.

The Board remands the claims for service connection and increased ratings due to pre-decisional duty to assist errors.

The Board remands the claims for further development, including directed research and VA examinations to address potential service connection based on chemical exposure.

The Board granted service connection for epilepsy, unspecified, diabetes mellitus, type II (diabetes), tinnitus, and posttraumatic stress disorder (PTSD). The petition to readjudicate the claims for obstructive sleep apnea and a right shoulder condition based on new evidence was also granted.

The Board remands the claims for service connection for diabetes mellitus type II, congestive heart failure, and hypertension due to missing treatment records and an insufficient medical opinion.

The Board granted service connection for the cause of the Veteran's death, finding that his alcohol-related causes of death were etiologically linked to a service-connected disability.

The Board denied the veteran's claims for service connection and increased ratings, finding no evidence of a current disability or sufficient link to military service.

The Board remands the claims for service connection for diabetes mellitus and hypertension to the AOJ for further development, as the AOJ failed to substantially comply with the Board's May 2025 remand instructions.

The Board granted service connection for tinnitus and denied it for bilateral hearing loss. Other claims were remanded for further development.

The Board denied service connection for type 2 diabetes mellitus as the evidence did not support a finding of in-service disease or injury indicative of type 2 diabetes mellitus, and there was no credible evidence to establish exposure to herbicide agents on a direct basis.

The Board denied service connection for diabetes mellitus as there was no evidence of a current disability. The claims for left ankle condition and heart condition were remanded for further development.

The Board granted service connection for diabetes mellitus II, as due to herbicide exposure during the Vietnam War under the PACT Act.

The Board denied service connection for diabetes mellitus type II and remanded the claim for further development regarding neuropathy of the left lower extremity.

The Board denied an initial rating in excess of 50 percent for obstructive sleep apnea and remanded the claim for service connection for diabetes mellitus type II.

The appeal seeking revision on the basis of clear and unmistakable error (CUE) of the October 2015 rating decision that assigned an effective date of June 24, 2015, for the award of service connection for diabetes mellitus type II was denied. The October 2015 rating decision was revised to reflect an earlier effective date of June 24, 2014, for the award of service connection for coronary artery disease (CAD).

The Board denied service connection for diabetes mellitus, type II and related conditions due to a lack of evidence linking the Veteran's current disabilities to his active service or toxic exposure at Camp Lejeune.

The Board denied service connection for anxiety and a higher rating for PTSD, but remanded claims for diabetes mellitus, skin markings from toxic exposure, left knee disorder, right knee disorder, and lumbar spine disorder.

The Board remands the claims for service connection for left knee strain, right knee strain, and diabetes due to a need for additional medical opinions.

The Veteran's appeal for increased ratings was denied, except for a grant of TDIU effective May 30, 2023.

The Board granted service connection for diabetic retinopathy, peripheral neuropathy of the upper extremities, kidney condition, obstructive sleep apnea, asthma, and tinnitus.